Rare diseases
Investigational molecules
Locations
Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors
The NetherlandsStudy on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis
BulgariaStudy on Leflunomide for Preventing Relapses in Patients with Polymyalgia Rheumatica During Steroid Reduction
The NetherlandsStudy Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients
DenmarkStudy on Reducing Immunosuppressive Drugs in Adults with Psoriatic Arthritis: Methotrexate Disodium, Abatacept, and Certolizumab Pegol
GermanyStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
BelgiumStudy Comparing Methotrexate or Leflunomide with Targeted Therapy vs. Methotrexate or Leflunomide with Drug Combination for Rheumatoid Arthritis Patients
FranceMethotrexate tapering versus usual care in elderly (≥70) patients with rheumatoid arthritis in low disease activity – drug combination study
DenmarkStudy on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids
The NetherlandsStudy on Methotrexate and Glucocorticoid Combination for Early Rheumatoid Arthritis, with Optional Etanercept for Non-Responders
BelgiumStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
FranceStudy on Leflunomide and Hydroxychloroquine for Patients with Primary Sjögren's Syndrome
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
